Skip to content

To check Efficacy of Angamardaprashamana mahakashaya in lumbar spondylosis

Clinical evaluation of angamarda prashamana mahakashaya and kativasti in the management of lumbar spondylosis (katigraha) - AMPMK KB

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036690
Enrollment
100
Registered
2021-09-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M479- Spondylosis, unspecified

Interventions

None listed

Sponsors

Nibedita Sarkar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: low back pain with sign and symptoms of Lumbar spondylosis disc Protrusion LBA with Lumbar spondylolisthesis grade 1 & 2 duratin of illness more than 3 months radiological finding of Lumbar Spondylosis

Exclusion criteria

Exclusion criteria: 1.associated with cardiac and CKD problem 2.ankylodging spondylitis 3.infectious arthritis Recent spinal surgeries Pregnant women congenital anomalies tumour

Design outcomes

Primary

MeasureTime frame
decrease in sign and symptoms of Lumbar spondylosisTimepoint: 60 days

Secondary

MeasureTime frame
verbal analogue scale visual analogue pain scaleTimepoint: 60days

Countries

India

Contacts

Public ContactDr Bishnu Prasad sarma

Govt ayurvedic College and hospital Guwahati

dr.bpsarma@gmail.com9864036018

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026